Director, Lung Cancer HTA & Value Evidence

Pfizer

Denver (CO)

Hybrid

USD 177,000 - 294,000

Full time

14 days+

Application generator

Stand out for this role — generate a tailored resume and cover letter in about a minute.

Get past ATS filters

Job summary

Pfizer is seeking a Director of HTA, Value & Evidence (HV&E) for the US Lung Cancer portfolio. The role leads US evidence generation, collaborates with Global HV&E and US Medical, and drives strategies to optimize patient access and appropriate use of medicines.

The position requires an advanced degree and 7+ years in HEOR (5+ for PharmD/PhD), with extensive experience in real-world evidence, economic modeling, and market access. Hybrid work with travel, competitive compensation, and benefits.

Qualifications

Broad health services research methods and tools knowledge.
Experience with health economic modeling and PRO data.
Ability to manage complex non-interventional studies.
Understanding of US drug development and healthcare environment.
Strong written and oral English communication skills.
Execution mindset with multitasking and budgeting capabilities.
Ability to influence across matrix teams and external partners.

Responsibilities

Lead development of evidence generation strategy for lung cancer portfolio.
Coordinate input from US Medical, Market Access, and partners to inform evidence needs.
Design and execute HEOR studies from concept to publication.
Develop US value & evidence materials like AMCP dossiers and literature reviews.
Provide strategic input into trial designs and PRO data interpretation.
Disseminate HEOR materials per regulatory guidance and SOPs.
Develop partnerships with external experts and payers to support asset strategies.